shareholder
Common Ownership May Reduce the Entry of Cheaper Generic Drugs
In new research, Martin Schmalz and Jin Xie examine how shareholder preferences influence the United States pharmaceutical industry. They find that generic-drug manufacturers sometimes harm their firms’ own value when doing so benefits shareholder portfolios, who frequently have stakes in competing brand-name firms.
Reclaiming Corporate Democracy
The following is an excerpt from Sarah C. Haan’s book, “Reclaiming Corporate Democracy.”
New Rules on Shareholder Voting Debate: Best Readers' Comment
The draft SEC regulation on shareholder proposal and proxy advisory firms will curb the initiative of individual shareholders to improve corporate governance and transparency...
